ICS Flashcards
ACUTE INFLAMMATION
Acute inflammation is the initial and often transient series of tissue reactions to
injury - may last from a few hours to a few days
Causes of acute inflammation:
6
- Microbial infections e.g pyogenic (pus causing) bacteria, viruses
- Hypersensitivity reactions e.g parasites, tubercle bacilli
- Physical agents e.g trauma, ionising radiation, heat, cold (frost-bite)
- Chemicals e.g corrosives, acids, alkalis, reducing agents
- Bacterial toxins
- Tissue necrosis e.g ischaemic infarction
Essential macroscopic appearances of acute inflammation:
5
- Redness - rubor
- Heat - calor
- Swelling - tumor
- Pain - dolor
- Loss of function is also characteristic
Acute inflammatory response process:
3
- Changes in vessel calibre (gets wider) and consequently increased vessel flow
- Increased vascular permeability and formation of the fluid exudate
- Formation of the cellular exudate - emigration of the neutrophil polymorphs into the extravascular space
THE diagnostic histological feature of acute inflammation is …
… the accumulation of neutrophil polymorphs within the extracellular space
Stages in neutrophil polymorph emigration
- Margination of neutrophils
- Adhesion of neutrophils
- Neutrophil emigration
- Diapedesis
Endogenous chemical mediators of acute inflammation cause:
5
• Vasodilation
• Emigration of neutrophils
• Chemotaxis (the attraction of neutrophil polymorphs towards certain
chemicals e.g at the site of inflammation)
• Increased vascular permeability
• Itching & pain
CHRONIC INFLAMMATION
• The subsequent and often prolonged tissue reactions to injury following the initial
response
• Can be defined as an inflammatory process in which lymphocytes, plasma cells and macrophages predominate
Characteristic microscopic features of chronic inflammation:
3
- The cellular infiltrate consists characteristically of lymphocytes, plasma cells &
macrophages
A granuloma is …
… an aggregate of epithelioid histiocytes
ORGANISATION IS …
The repair of specialised tissue by …
… the formation of a fibrous scar
Cells that regenerate:
6
- Hepatocytes
- Pneumocytes
- All blood cells
- Gut epithelium
- Skin epithelium
- Osteocytes
Cells that do not regenerate:
2
- Myocardial cells
- Neurones
THROMBOSIS
why is it different from a clot?
- The solidification of blood contents that forms within the vascular system
during life
Blood coagulated outside of the vascular system or after death
Aspirin can … ?
Warfarin … ?
INHIBIT PLATELET AGGREGATION thus a low dose can help prevent thrombosis. In severe cases, warfarin can be used (inhibits vitamin K (clotting factor) - thereby preventing clotting)
EMBOLISM
An embolus is a mass of material in the vascular system able to lodge in a
vessel and block its lumen
ISCHAEMIA
A reduction in blood flow to a tissue or part of the body caused by constriction
or blockage of the blood vessels supplying it
INFARCTION
The death (necrosis) of part or the whole of an organ that occurs when the artery supplying it becomes obstructed
GANGRENE
When whole areas of a limb or a region of the gut have their arterial
supply cut off and large areas of mixed tissue die in bulk
ATHEROSCLEROSIS
Disease characterised by the formation of atherosclerotic plaques in the intima of
large (aorta) and medium-sized arteries, such as the coronary arteries
Atherosclerosis can cause …
6
- Cerebral infarction
- Carotid atheroma - emboli causing transient
ischaemic attacks or cerebral infarcts - Myocardial infarction
- Aortic aneurysm - rupture causes certain
death - Peripheral vascular disease
- Gangrene
Risk factors for Atherosclerosis risk factors …
6
- Hypercholesterolaemia: • Essentially high cholesterol levels • MOST IMPORTANT RISK FACTOR • It can cause plaque formation and growth in the absence of other known risk factors • Lipids directly damage endothelial cells - Smoking: • Increases blood pressure • Damages endothelial cells - Hypertension - Diabetes - Male gender - Increasing age
Preventive and therapeutic measures to atherosclerosis:
5
- Smoking cessation
- Control of blood pressure
- Weigh reduction
- Low dose aspirin - inhibits the aggregation of platelets, advised for people
with clinical evidence of atheromatous disease - Statins - cholesterol reducing drug
ANEURYSMS
A localised permanent dilation of part of the vascular tree
APOPTOSIS
A physiological cellular process in which a defined and programmed
sequence of intracellular events leads to the removal of a cell WITHOUT the
release of products harmful to surrounding cells
Inhibitors of apoptosis
4
- Growth factors
- Extracellular cell matrix
- Sex steroids
- Some viral proteins
Inducers of apoptosis
8
- Growth factor withdrawal
- Loss of matrix attachment
- Glucocorticoids
- Some viruses
- Free radicals
- Ionising radiation
- DNA damage
- Ligand-binding at ‘death receptors’
Apoptosis intrinsic pathway …
2
Uses the pro- and anti-apoptotic members of the Bcl-2 family:
• Bcl-2 can inhibit many factors that induce apoptosis
• Bax forms Bax-Bax dimers which enhance apoptotic stimuli
CONGENITAL DISEASE
• Simply a disease that is present at birth
INHERITED
Disease caused by an inherited genetic abnormality
IS GENETIC
doesn’t need to be present at birth
SPONTANEOUS
Disease caused by a spontaneous mutation
IS GENETIC
ENVIRONMENTAL
Acquired by environmental factors
NON-GENETIC
ACQUIRED DISEASE
• Disease caused by non-genetic environmental factors
HYPERTROPHY
• Increase in cell size without cell division (SAME NUMBER)
HYPERPLASIA
Increase in cell number by mitosis
ATROPHY
The decrease in size of an organ or cell by reduction in cell size and/or
reduction in cell numbers, often by a mechanism involving apoptosis
NECROSIS
Traumatic cell death which induces inflammation and repair
METAPLASIA
The change in differentiation of a cell from one fully-differentiated cell type to
a different fully-differentiated cell type
DYSPLASIA
Imprecise term for the morphological changes seen in cells in the progression
to becoming cancer
CARCINOGENESIS
The transformation of normal cells to neoplastic cells through permanent
genetic alterations or mutations
NEOPLASIA IS …
4
-Autonomous
• Abnormal
• Persistent
• New growth
NEOPLASM
A lesion resulting from the autonomous or relatively autonomous abnormal
growth of cells which persists after the initiating stimulus has been removed - a
new growth
TUMOURS
Any abnormal swelling
Tumours include:
4
- Neoplasm
- Inflammation
- Hypertrophy
- Hyperplasia
Tumours can cause morbidity and mortality due to:
5
- Pressure on adjacent structures (e.g. benign meningeal tumour causing epilepsy)
- Obstruction to the flow of fluid (e.g. benign epithelial tumour blocking duct)
- Production of a hormone (e.g. benign thyroid tumour causing thyrotoxicosis (excessive thyroid hormone)
- Transformation into a malignant neoplasm
- Anxiety & stress since patient thinks the lesions may be something more sinister
Malignant neoplasms can cause morbidity and mortality due to:
(7)
• Pressure on and destruction of adjacent tissue
• Formation of secondary tumours (metastases)
• Blood loss from ulcerated surfaces
• Obstruction of flow (e.g. malignant tumour of the colon causing intestinal obstruction)
• Hormone production
• Paraneoplastic effects resulting in weight loss and debility
• Anxiety & pain - many cancer cause no pain until quite late
into the disease
HISTEOGENESIS
the specific cell or origin of a tumour
Histogenic classification major
categories of origin:
(3)
• Epithelial cells (forming carcinomas)
• Connective tissues (forming sarcomas)
• Lymphoid (ONLY GIVE RISE TO MALIGNANT NEOPLASMS) and/or
haemopoietic organs (forming lymphomas or leukaemias)
MALIGNANT TUMOUR GRADING
- Well differentiated - Grade 1
- Moderately differentiated - Grade 2
- Poorly differentiated - Grade 3
Nomenclature of Neoplasia of Connective tissue and other mesenchymal
tumours:
BENIGN (7)
named according to cell of origin and behavioural
classification
B- named after cell or tissue of origin suffixed by -oma:
- Lipoma: benign tumour of adipocytes
- Rhabdomyoma: benign tumour of striated muscle
- Leiomyoma: benign tumour of smooth muscle cells
- Chondroma: benign tumour of cartilage
- Osteoma: benign tumour of bone
- Angioma: benign vascular tumour
- Neuroma: benign tumour of the nerve
Nomenclature of Neoplasia of Connective tissue and other mesenchymal
tumours:
MALIGNANT (7)
M- always designated sarcoma, prefixed by the name that describes the cell or tissue of origin:
- Liposarcoma: malignant tumour of adipocytes
- Rhabdomyosarcoma: malignant tumour of striated muscle
- Leiomyosarcoma: malignant tumour of smooth muscle cells
- Chondrosarcoma: malignant tumour of cartilage
- Osteosarcoma: malignant tumour of bone
- Angiosarcoma: malignant vascular tumour
- Neurosarcoma: malignant tumour of the nerve
Exceptions to the rules of nomenclature:
- OMAS (3)
- MALIGNANT TUMOURS (3)
- NAMED (4)
- RANDOM (2)
• Not all -omas are neoplasms:
- Granuloma - chronic inflammation
- Mycetoma - fungus in body
- Tuberculoma - mass of TB
• Not all malignant tumours are carcinoma or sarcoma:
- Melanoma - malignant neoplasm of melanocytes
- Mesothelioma - malignant tumour of mesothelial cells (line body
cavities and outer surface of internal organs, secrete lubricating
fluid)
- Lymphoma - malignant neoplasm of lymphoid cells, all are
malignant
• Tumours named after the person who first discovered/described them:
- Burkitt’s lymphoma - B-cell lymphoma caused by Epstein Barr virus
- Ewing’s sarcoma - malignant tumour of bone
- Hodgkin’s lymphoma - malignant lymphoma characterised by the
presence of Reed-Sternberg cells
- Kaposi’s sarcoma - malignant neoplasm derived from vascular
endothelium, commonly associated with AIDs
• Teratoma - neoplasm of germ cell origin that forms cells representing all
three germ cell layers of the embryo; ectoderm, mesoderm & endoderm
• Carcinosarcomas - mixed malignant tumours showing characteristics of
epithelium & connective tissue
CARCINOGEN
An environmental agent participating in the causation of tumours
Classes of carcinogen
5
- Chemical
- Viruses
- Ionising & non-ionising radiation
- Hormones, parasites & mycotoxins
- Miscellaneous
Host factors that influence carcinogenesis:
5
Race
- Diet
- Constitutional factors - age, gender etc.
- Premalignant lesions
- Transplacental exposure
ONCOGENES
These are genes driving the neoplastic behaviour of cells
Three major families OF Proteinases and inhibitors OF INVASION:
- Interstitial collagenases; degrade types I,II & III collagen
- Gelatinases; degrade type IV collagen and gelatin
- Stromelysins; degrade type IV collagen and proteoglycans
Most important sole criterion for malignancy IS
INVASION
METASTASIS
The process whereby malignant tumours spread from their site of origin
(the primary tumour) to form other tumours (secondary tumours) at distant
sites
Metastasis sequence
6
- Detachment of tumour cells from their neighbours
- Invasion of the surrounding connective tissue to reach
conduits of metastasis i.e. blood & lymphatic vessels - Intravasation into the lumen of vessels
- Evasion of host defence mechanisms, such as natural killer
cells in the blood - Adherence to endothelium at a remote location
- Extravasation of the cells from the vessel lumen into the
surrounding tissue
Bone is a site favoured by haematogenous metastases
from five carcinomas:
- Lung
- Breast
- Kidney
- Thyroid
- Prostate
TUMOUR GRADE
This is an assessment of its degree of malignancy or aggressiveness (can be
inferred from its histology)
TUMOUR STAGE
This is the extent of a tumours spread
TUMOUR STAGE - how to classify
TNM system:
• T
- Refers to the primary tumour and is suffixed by a number that
denotes tumour size
- The number varies according to the organ harbouring the tumour
• N
- Refers to lymph node status and is suffixed by a number that
denotes the number of lymph nodes or groups of lymph nodes
containing metastases
• M
- Refers to the anatomical extent of distant metastases
UK screening programs
- Cervical cancer
- Breast cancer
- Colorectal cancer
Biases in screening programs
- Lead time bias:
• Earlier detection does not affect the inevitable fatal outcome, but
prolongs the apparent survival time - Length bias:
• Preferential detection of slow growing tumours with intrinsically better
prognosis - Overdiagnosis bias:
• Diagnosis of lesions that, although histologically malignant, are
clinically relatively harmless - Selection bias:
• Volunteers for screening are more at risk of good-prognosis tumours
COMPLEMENT
• A complex series of interacting plasma proteins which form a major
effector system for antibody-mediated immune reactions
The major purpose of the complement pathway is
to remove or destroy
antigen, either by direct lysis or by opsonisation
When activated by coming into contact with pathogen complement can:
(4)
- Lyse microbes directly (Membrane Attack Complex - when a group
of complement proteins make a hole in a pathogen which causes
an inrushing of fluids that results in lysis and thus the destruction
of the pathogen) - Increase chemotaxis (C3a & C5a)
- Enhance inflammation
- Induce opsonisation (C3b) - process by which an antigen becomes
coated with substances (i.e. complement) that make it more easily
engulfed by phagocytic cells since macrophages have special
receptors for specific complement proteins
ANTIBODIES AKA IMMUNOGLOBULINS
A protein produced in response to an antigen. It can only bind with the
antigen that induced its formation i.e. specificity
ANTIGEN
A molecule that reacts with preformed antibody and specific
receptors on T and B cells
EPITOPE
The part of the antigen that binds to the antibody/receptor binding
site
AFFINITY
A measure of binding strength between an epitope and an
antibody binding site - the higher the affinity the better
CYTOKINES
Soluble proteins secreted by lymphocytes or macrophages/monocytes
that act as stimulatory or inhibitory signals between cells
Adaptive immunity hallmarks:
7
** Cell mediated - T cells for intracellular microbes
** Antibodies - B cells for extracellular microbes
SPECIFIC
• Response specific to antigen
• Memory to specific antigen
• Quicker response
• Requires lymphocytes